Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT01207440 · COMPLETED
Trial details
- NCT number
- NCT01207440
- Sponsor
- Ariad Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-30
- Primary completion
- 2018-12-20
- Enrollment
- 449
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.